cbil.upenn.edu:RAD.Protocol:5539:Protocol - cbil.upenn.edu:RAD.Protocol:5539:Protocol

Type
compound
Description
To induce Foxa2 ablation, tamoxifen pellets (free base, 25 mg/pellet, 21-day release, E-361, Innovative Research of America, Sarasota, FL) were implanted subcutaneously into the mice. Analysis was performed after 3-week of implantation.
Links
Experiment E-CBIL-39